

RSI: Part II
May 3, 2024
Pharmacists Christine Groth, Angela Slampak-Cindric, and Kevin Kaucher discuss RSI guidelines, pharmacotherapy, non-pharmacologic recommendations, and potential research ideas. They delve into the importance of evidence-based practices, medication safety concerns, and the impact of guidelines on clinical practice.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11
Intro
00:00 • 3min
Discussing Complex Specialty Care and Return on Investment
03:00 • 2min
Development of Society of Critical Care Medicine Guidelines for Rapid Sequence Intubation in Critically Ill Patients
04:42 • 17min
Evaluation of Evidence Based on GRADE Framework and Medication Safety Concerns in Medical Guidelines
21:26 • 22min
Semi-Fowler Position and Pre-oxygenation Techniques in Rapid Sequence Intubation
43:40 • 4min
Critical Evaluation of NG Tube in RSI Patients at Risk of Aspiration
48:06 • 2min
Evolution and Impact of Evidence-Based Guidelines in Healthcare Practice
50:00 • 12min
Leadership, Evidence Evaluation, and Future Research in Medicine
01:01:53 • 8min
Complex Review Process of Guidelines Sponsored by SCCM and Board
01:09:23 • 2min
Importance of Research and Collaboration in Rapid Sequence Intubation (RSI)
01:11:22 • 12min
Closing Notes and Disclaimer
01:23:00 • 2min